InflaRx NV (IFRX)
1.11
-0.04
(-3.48%)
USD |
NASDAQ |
Nov 18, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
InflaRx Total Assets (Quarterly) : 183.23M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 183.23M |
| June 30, 2026 | 190.83M |
| March 31, 2026 | 56.33M |
| September 30, 2025 | 76.56M |
| June 30, 2025 | 86.21M |
| March 31, 2025 | 93.98M |
| September 30, 2024 | 88.94M |
| June 30, 2024 | 99.71M |
| March 31, 2024 | 115.66M |
| December 31, 2023 | 132.79M |
| September 30, 2023 | 137.09M |
| June 30, 2023 | 145.06M |
| March 31, 2023 | 93.77M |
| December 31, 2022 | 109.29M |
| September 30, 2022 | 108.86M |
| June 30, 2022 | 119.84M |
| March 31, 2022 | 128.04M |
| December 31, 2021 | 142.31M |
| Date | Value |
|---|---|
| September 30, 2021 | 149.94M |
| June 30, 2021 | 160.13M |
| March 31, 2021 | 173.06M |
| December 31, 2020 | 107.94M |
| September 30, 2020 | 118.81M |
| June 30, 2020 | 116.66M |
| March 31, 2020 | 124.56M |
| December 31, 2019 | 136.47M |
| September 30, 2019 | 154.29M |
| June 30, 2019 | 165.03M |
| March 31, 2019 | 173.99M |
| December 31, 2018 | 182.01M |
| September 30, 2018 | 191.22M |
| June 30, 2018 | 193.34M |
| March 31, 2018 | 142.95M |
| December 31, 2017 | 149.16M |
| September 30, 2017 | 28.38M |
| June 30, 2017 | 30.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 22.91B |
| Immatics NV | 642.58M |
| Oncolytics Biotech, Inc. | 5.832M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.55M |
| Shareholders Equity (Quarterly) | 163.68M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 7.263 |
| Net Debt Paydown Yield | -0.01% |